MAIA Biotechnology Inc. (MAIA) — Financial Flexibility Index
MAIA Biotechnology Inc. (MAIA) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-5.31 Million (operating CF $-5.31 Million minus capex $0.00) represents -1% of total liabilities ($7.56 Million). Also explore MAIA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MAIA Biotechnology Inc. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for MAIA Biotechnology Inc. across 7 annual periods. See net asset quality index of MAIA Biotechnology Inc. to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for MAIA Biotechnology Inc. (2019–2025)
Year-by-year free cash flow to debt coverage for MAIA Biotechnology Inc.. For the full company profile including market capitalisation, see market cap of MAIA Biotechnology Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.57x | $-18.84 Million | $-18.84 Million | $7.33 Million | ▼ -6.8% |
| 2024 | -2.41x | $-15.70 Million | $-15.70 Million | $6.52 Million | ▼ -30.6% |
| 2023 | -1.84x | $-13.07 Million | $-13.07 Million | $7.09 Million | ▲ +46.4% |
| 2022 | -3.44x | $-12.10 Million | $-12.10 Million | $3.51 Million | ▼ -79.2% |
| 2021 | -1.92x | $-4.12 Million | $-4.12 Million | $2.15 Million | ▼ -146.2% |
| 2020 | -0.78x | $-1.84 Million | $-1.84 Million | $2.36 Million | ▲ +79.6% |
| 2019 | -3.82x | $-1.57 Million | $-1.57 Million | $409.74K | — |